Form 4 for BNTX BioNTech SE
Accepted 2026-09-09 17:29:51 ET · period of report 2026-09-08 · accession 0002123975-26-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-09-09 17:29 | 2026-09-08+ | BNTX | Sahin Ugur | CEO, 10% | S - Sale | $98.50 | -73.0K | 708.7K | -9% | -$7.19M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-09-08 | S | D | 37,000 | $99.20 | 744,709 | D | — | — | |
| 2 | Common | Ordinary Shares | 2026-09-09 | S | D | 36,000 | $97.78 | 708,709 | D | — | — |